Last reviewed · How we verify
NCT06290648: FNP
Forging New Paths: Building Interventions to Treat Criminogenic Needs in Community Based Mental Health Settings
NA trial testing Forging New Paths in Mental Illness in 72 participants. Participants enrolled and being followed up; not accepting new ones.
30 January 2026
Quick facts
| Lead sponsor | University of North Carolina, Chapel Hill |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 72 |
| Start date | 1 April 2024 |
| Primary completion | 30 January 2026 |
| Estimated completion | 30 January 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Forging New Paths
Conditions studied
- Mental Illness — all drugs for Mental Illness →
Sponsor
University of North Carolina, Chapel Hill
Who can join
18 and older, any sex, with Mental Illness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to conduct a preliminary test of the effectiveness of Forging New Paths for people with mental illness with criminal legal system contact. The main question\[s\] it aims to answer are: 1. To examine the effectiveness of Forging New Paths at improving the primary study outcomes (aggression and community tenure). 2. To test the ability of Forging New Paths to engage the study treatment targets (impulsivity and criminal attitudes) Participants will complete a screening interviews to see if they are eligible. Participants who are eligible will be randomly assigned to participate in one of two study conditions: Forging New Paths and usual care or usual care alone. All participants who are assigned to a study condition will participate in up to three additional research interviews. Researchers will also collect information about study outcomes using administrative records.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Forging new paths in the development of community mental health interventions for people with mental illness at risk of criminal legal system contact.
Wilson AB, Bonfine N, Phillips J, Swaine J, et al · · 2025 · PMID 39794641 · DOI 10.1186/s40352-025-00315-x
Verify or expand the search:
- PubMed search for NCT06290648
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Mental Illness
Currently open trials in the same condition.
- NCT07396623 — Validation of French PHQ-4 and PC-PTSD-5 Screening Scales · recruiting
- NCT05776316 — Harm Reduction Services · NA · recruiting
- NCT04881084 — Exploring Empathy and Compassion Using Digital Narratives · NA · recruiting
- NCT06315114 — A Transdiagnostic Mentalization-based Intervention for Parents With Mental Disorders · NA · recruiting
- NCT04366531 — Successful Transitions and Reintegration Tools for Veterans (START-VETS) · NA · recruiting
Other University of North Carolina, Chapel Hill trials
Trials by the same sponsor.
- NCT06841913 — Woodsmoke Exposure, Influenza Infection, and Nasal Immunity · Phase 4 · suspended
- NCT07383428 — The INICIO-Guatemala Study · NA · not yet recruiting
- NCT07528443 — Ultraprocessed Foods in Colombia · NA · not yet recruiting
- NCT07507370 — CARED : A Novel Rapid Treatment Paradigm for Depression · NA · not yet recruiting
- NCT07534254 — Piloting a Generative Artificial Intelligence Chatbot in a Mobile Weight Loss Program · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06290648 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of North Carolina, Chapel Hill
- Last refreshed: 22 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06290648.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing